Iliac stent market
DUBLIN, March 18, 2024 (GLOBE NEWSWIRE) — Iliac Stents Market by Type (Self-Expanding Stents, Balloon-Expandable Stents) and Arterial Lesions (Common Iliac Artery Lesions, Severely Calcified Lesions) Size, Share and Trend Analysis Report), Forecast by End Use, Region, and Segment, 2024-2030″ report added ResearchAndMarkets.com Recruitment.
The global iliac stent market size is expected to reach USD 1.53 billion by 2030 and is projected to grow at a CAGR of 5.8% from 2024 to 2030.
This market is expected to grow due to factors such as increasing prevalence of peripheral artery disease, increasing advances in medical technology, and growing awareness of minimally invasive procedures as effective treatment options for cardiovascular diseases.
Industry growth is driven by new product development and tailored procedures that have enhanced patency. For example, self-expanding stents have shown excellent results in the treatment of external iliac arteries. Additionally, increasing prevalence of peripheral artery disease (PAD) is expected to drive the growth of the iliac stent market. According to an October 2023 Institute for Health Metrics and Evaluation article, the global prevalence of PAD is estimated to be 1.52%, or approximately 113 million people. Additionally, a 2022 NCBI article predicts that the annual incidence of PAD will be close to 10 million people.
Increased strategic initiatives among major iliac stents companies are expected to drive the growth. For example, in January 2024, Zylox-Tonbridge Medical Technology Co., Ltd. received marketing approval from the National Medical Products Authority (NMPA) for its peripheral venous stent system. Additionally, in October 2023, Getinge AB announced the launch of its product iCast covered stent system for the treatment of iliac artery occlusion in the United States.
Iliax Stent Market Report Highlights
-
The iliac stent market in the healthcare industry is estimated at USD 1.03 billion in 2023 and is expected to reach USD 1.53 billion in 2030
-
The iliac stent market is expected to reach USD 1.53 billion by 2030, growing at a CAGR of 5.8% from 2024 to 2030.
-
In 2023, North America accounted for the largest share of the iliac stent market with a revenue share of 43.7%. Increasing elderly population in the US susceptible to PAD is expected to increase the demand for stent implantation, thereby contributing significantly to the market growth during the forecast period
-
By type, the self-expanding stent segment accounted for the largest revenue share of 60.4% in 2023. This was driven by positive long-term clinical trial results for these stents, which are expected to provide confidence to healthcare providers.
-
By arterial lesions, the common iliac artery lesions segment accounted for the largest revenue share of 60.5% in 2023, with the increasing number of patients suffering from high cholesterol and obesity, as these conditions cause plaque accumulation, iliac stents. demand is expected to increase.Anything that narrows or obstructs the lumen of an artery
-
By end use, the hospital sector accounted for the dominant revenue share of 61.7% in 2023. The hospital serves as a referral center where patients receive comprehensive care including diagnostic imaging, medical management, and interventional procedures such as iliac stent placement.
Key attributes:
|
report attributes |
detail |
|
number of pages |
130 |
|
Forecast period |
2023-2030 |
|
Estimated market value in 2023 (USD) |
$1.03 billion |
|
Projected market value to 2030 (USD) |
$1.53 billion |
|
compound annual growth rate |
5.8% |
|
Target area |
global |
Main topics covered:
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Iliac Stents Market Variables, Trends and Scope
3.1. Market system outlook
3.2. Market trends
3.2.1. Analysis of market drivers
3.2.1.1. Increased prevalence of peripheral artery disease (PAD)
3.2.1.2. Technological advances in iliac stents
3.2.1.3. Increase in the number of product approvals in developed and developing countries
3.2.2. Market restraint analysis
3.2.2.1. Lack of reimbursement policy for venous stenting
3.2.2.2. Product Recall
3.3. Iliac Stents Market Analysis Tools
Chapter 4 Ilium Stent Market: Type Estimation and Trend Analysis
4.1. Iliac Stent Market: Type Dashboard
4.2. Iliac Stent Market: Analysis of Type Movement
4.3. Iliac Stents Market Size, By Type, Forecast and Trend Analysis from 2018 to 2030 (USD Million)
4.4. Self-expanding stents
4.5. Balloon expandable stents
4.6. Others
Chapter 5 Iliac Stent Market: Arterial Lesion Estimation and Trend Analysis
5.1. Iliac Stents Market: Arterial Lesion Dashboard
5.2. Iliac Stents Market: Arterial Lesion Movement Analysis
5.3. Iliac Stents Market Size, Forecast and Trend Analysis by Arterial Lesion, 2018 to 2030 (USD Million)
5.4. Common iliac artery lesions
5.5. Severely calcified lesions
5.6. Completely obstructive lesions
Chapter 6 Ilium Stents Market: End Use Estimation and Trend Analysis
6.1. Iliac Stent Market: End Use Dashboard
6.2. Iliac Stents Market: End-use Migration Analysis
6.3. Iliac Stents Market Size, By End Use, Forecast and Trend Analysis from 2018 to 2030 (USD Million)
6.4. Hospital
6.5. Outpatient facilities
6.6. Others
Chapter 7 Iliac Stents Market: Regional Estimates and Trend Analysis by Country, Type, Arterial Lesion, and End-Use
7.1. Regional Dashboard
7.2. Market size and forecast trend analysis, 2018 to 2030
Chapter 8 Competitive Environment
8.1. Recent developments and impact analysis by key market participants
8.2. Company/Competitor Classification
8.3. Vendor landscape
-
B.D.
-
abbot
-
boston scientific
-
WL Gore & Associates
-
Cook
-
medtronic
-
blood vessels
-
Terumo
-
Getinge
-
biotronik
For more information on this report, please visit https://www.researchandmarkets.com/r/ik0ddj.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.
attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
